EP0009865A1 - Verfahren zur stereoselektiven Synthese des E-Isomeren von Arylalkyloximen - Google Patents

Verfahren zur stereoselektiven Synthese des E-Isomeren von Arylalkyloximen Download PDF

Info

Publication number
EP0009865A1
EP0009865A1 EP79301528A EP79301528A EP0009865A1 EP 0009865 A1 EP0009865 A1 EP 0009865A1 EP 79301528 A EP79301528 A EP 79301528A EP 79301528 A EP79301528 A EP 79301528A EP 0009865 A1 EP0009865 A1 EP 0009865A1
Authority
EP
European Patent Office
Prior art keywords
isomer
ketoxime
aryl alkyl
isopropyl
anhydrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP79301528A
Other languages
English (en)
French (fr)
Inventor
Jill Helaine Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience Inc USA
Original Assignee
Rhone Poulenc Industries SA
Rhone Poulenc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Industries SA, Rhone Poulenc Inc filed Critical Rhone Poulenc Industries SA
Publication of EP0009865A1 publication Critical patent/EP0009865A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms

Definitions

  • This invention relates to a process for the conversion of mixtures of E and Z isomers of certain ketoximes to 98% or greater pure E isomer.
  • This invention provides a process for producing 98% or greater pure E isomer of an aryl alkyl ketoxime having the formula: wherein Ar is phenyl; phenyl substituted in the 2- to 6- position with 1-5 halogen (Cl, Br, F, I), C 1 - C 4 alkyl, C l - C 4 alkoxy, C l - C 4 alkylthio, methylenedioxy, ethylenedioxy, isopropylenedioxy, trifluoromethyl, C l -C 4 haloalkyl, C 1 - C 4 alkylthioalkyl, C 2 - C 4 alkenyl, C 2 - C 4 alkynyl, cyano, C 2 - C 4 cyanoalkyl, C 2 - C 4 carboalkoxy, C 1 - C 4 alkylsulfonyl, C 2 - C 8 alkoxyalkyl, C 2 - C 4 haloalkenyl,
  • aryl alkyl ketoximes treated in accordance with this invention include:
  • mixtures of E and Z isomers of the aryl alkyl ketoximes are precipitated as the E isomer immonium complex by treating a solution of the mixture in an anhydrous solvent with anhydrous protic or Lewis-acids. It has been found that, unexpectedly, the E isomer in the mixture is preciptated as an immonium salt and the Z isomer isomerizes to the E isomer. Upon neutralization about 98% of the original mixture of isomers is recovered in the form of E isomer.
  • the organic solvent used can be any of the well known solvents used in organic synthesis operations, so long as the solvent is anhydrous.
  • Typical utilizable anhydrous organic solvents include hydrocarbons, such as hexane, cyclohexane, toluene, and xylene; chlorinated hydrocarbons, such as chloroform and carbon tetrachloride; ethers, such as diethyl ether, tetrahydrofuran and dioxane; and ketones, such as acetone and 2-butanone.
  • the amount of solvent used is not a critical factor, as it simply serves as a medium for the acid treatment. In general, between about one part and about 10 parts solvent per part aryl alkyl ketoxime can be used.
  • the acid used to precipitate the immonium salt of the aryl alkyl ketoxime will be an anhydrous organic or inorganic protic or Lewis acid.
  • Typical acids include Lewis acids, such as boron trifluoride and aluminum chloride; mineral acids, such as sulfuric acid, orthophosphoric acid and polyphosphoric acids; hydrogen halide acids, such as hydrobromic acid and hydrochloric acid.
  • HC1 and BF 3 are preferred because they are gases and easily handled. At least a stoichiometric amount of .the acid must be used, although an excess over the stoichiometric up to the point of saturation of the ketoxime solution is not detrimental.
  • the reaction of the aryl alkyl ketoxime with the acid to form the immonium complex or salt can be carried out at temperatures between about -20°C. and about 150°C., although temperatures between about 10°C. and about 40 o C. are preferred. The reaction is carried out until precipitation is complete, usually within one hour.
  • the solid immonium complex is isolated, as by filtration, and washed with solvent, preferably the same as used in the initial solution. Then, the E ketoxime isomer immonium complex is neutralized to obtain the free E ketoxime. Neutralization is readily carried out using dilute aqueous solutions of alkali metal salts, particularly Na and K, of weakly ionized organic acids, such as carbonic acid and oxalic acid, e.g., sodium carbonate, potassium carbonate, sodium bicarbonate, sodium oxalate, and potassium oxalate. In general, the concentration of the aqueous solution can be between 10 weight per cent and 15 weight per cent and usually 10 weight per cent. A large excess of the aqueous solution is used, in the order of 3 parts per part immonium complex.
  • alkali metal salts particularly Na and K
  • weakly ionized organic acids such as carbonic acid and oxalic acid
  • the concentration of the aqueous solution can be between 10 weight per cent and
  • the aryl alkyl ketoximes are prepared from aryl alkyl ketones and excess hydroxylamine hydrochloride in the presence of a base, in a manner familiar to those skilled in the art. In practice, the aryl alkyl ketoximes usually are obtained as a mixture of E and Z isomers.
  • the ketoximes are precursors for preparing active insecticides by converting them to ketoximinoethers for example, by reacting the sodium ketoximate with substituted alkyl bromides, such as m-phenoxybenzylbromide.
  • ketoxime ratios are ascertained using two corroborative methods: (1) comparison of the E/Z isomer ratio of the thermally stable trimethyl silyl derivative of the oxime before and after acid (HC1) treatment, by gas chromatograph analysis and (2) comparison of the relative integration in the H 1 HMR of the separate resonances for the E and Z isopropyl methine protons, before and after the acid (HC1) treatment.
  • the E stereochemistry was concluded from both H l and C13 chemical shift data. References: J. Am. Chem. Soc. 86, 4373 (1964); Tet. 23, 1079-1095 (1967); J. Am. Chem. Soc. 94, 4897 (1972); J.O.C. 39(8), 1017 (1974).
  • a 60:40 E/Z isomeric mixture of p-chloro- isobutyrophenone oxime (151g., 0.76m) was dissolved in 50.0 ml of anhydrous diethyl ether. The solution was saturated with anhydrous HC1, whereupon a voluminous amount of pure E oxime hydrochloride precipitated. The solid was filtered and washed well with dry ether. The dried hydrochloride salt was then added in portions to a vigorously stirring solution of 2500 ml. of 10% Na 2 C0 3 . The free oxime was filtered; washed with H 2 0 until washings were neutral,, and dried, under reduced pressure to yield 145g. of 98% E p-chlorophenyl isopropyl ketoxime.
  • Example 6 is a typical illustration of a sterospecific synthesis of an insecticidally active ketoximinoether using the E oxime of Example 1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP79301528A 1978-08-16 1979-07-31 Verfahren zur stereoselektiven Synthese des E-Isomeren von Arylalkyloximen Withdrawn EP0009865A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/934,142 US4158015A (en) 1978-08-16 1978-08-16 Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
US934142 1978-08-16

Publications (1)

Publication Number Publication Date
EP0009865A1 true EP0009865A1 (de) 1980-04-16

Family

ID=25465033

Family Applications (1)

Application Number Title Priority Date Filing Date
EP79301528A Withdrawn EP0009865A1 (de) 1978-08-16 1979-07-31 Verfahren zur stereoselektiven Synthese des E-Isomeren von Arylalkyloximen

Country Status (7)

Country Link
US (1) US4158015A (de)
EP (1) EP0009865A1 (de)
JP (1) JPS5551049A (de)
DD (1) DD146592A5 (de)
DK (1) DK341779A (de)
IL (1) IL57990A0 (de)
ZA (1) ZA794299B (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352832A1 (de) * 1988-07-05 1990-01-31 Akzo N.V. Verbindungen mit bronchodilatatorischer Aktivität
EP0435687A2 (de) * 1989-12-28 1991-07-03 Sumitomo Chemical Company, Limited Verfahren zur Isomerisierung von Oximethern
WO1993021157A2 (de) * 1992-04-22 1993-10-28 Hoechst Schering Agrevo Gmbh Akarizide, insektizide und nematizide substituierte (hetero)-aryl-alkyl-ketonoxim-o-ether, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
EP0596692A2 (de) * 1992-11-02 1994-05-11 Shionogi Seiyaku Kabushiki Kaisha Verfahren zur Herstellung von (E)-Alkoximino- oder Hydroxyiminoacetamidverbindungen und Zwischenprodukte
US5627284A (en) * 1992-11-02 1997-05-06 Shionogi & Co., Ltd. Process for producing (E)-alkoxyimino or hydroxyiminoacetamide compounds and intermediates therefor
US6670382B2 (en) 2000-06-15 2003-12-30 Taisho Pharmaceutical Co., Ltd. Hydroxyformamidine derivatives and medicines containing the same
CN103497129A (zh) * 2013-09-05 2014-01-08 湖南海利化工股份有限公司 一种反式硫氟肟醚的制备方法
CN109996793A (zh) * 2017-02-08 2019-07-09 日产化学株式会社 肟基化合物的几何异构体的制造方法
US11629124B2 (en) 2017-03-09 2023-04-18 Novartis Ag Solid forms comprising an oxime ether compound, compositions and methods of use thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260555A (en) * 1979-11-07 1981-04-07 Ciba-Geigy Corporation Process for the manufacture of cyanooximinonitriles
GB2092128B (en) * 1981-01-30 1984-11-21 Kodak Ltd Preparation of 2-halo-3/nitro-5-acyl thiophenes and intermediate compounds
US4705896A (en) * 1984-06-25 1987-11-10 Allied Corporation Novel extractants for the recovery of palladium
JPH0546711Y2 (de) * 1989-02-27 1993-12-07
US5514812A (en) * 1994-06-10 1996-05-07 Warner-Lambert Company Preparation of stereochemically pure oximes with muscarinic activity
CZ288053B6 (cs) * 1995-04-08 2001-04-11 Basf Aktiengesellschaft Způsob výroby izomerů alfa-bis-oximů
IL129793A (en) * 1997-01-27 2003-01-12 Warner Lambert Co Process for producing (z)-azabicyclo oxime ethers
JPWO2011093423A1 (ja) * 2010-01-29 2013-06-06 田辺三菱製薬株式会社 (e)−ヒドロキシイミノフェニル酢酸誘導体の製法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079149A (en) * 1977-06-30 1978-03-14 Shell Oil Company Benzyl oxime ethers
DE2806664A1 (de) * 1977-02-18 1978-08-24 Shell Int Research Benzyloximaether, verfahren zu ihrer herstellung und ihre verwendung zur schaedlingsbekaempfung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806664A1 (de) * 1977-02-18 1978-08-24 Shell Int Research Benzyloximaether, verfahren zu ihrer herstellung und ihre verwendung zur schaedlingsbekaempfung
US4079149A (en) * 1977-06-30 1978-03-14 Shell Oil Company Benzyl oxime ethers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HOUBEN-WEYL "Methoden der organischen Chemie" 4th edition, Vol. X/4, 1968, GEORG THIEME VERLAG, Stuttgart pages 287 to 291 * page 287 * *
JOURNAL OF MEDICINAL CHEMISTRY, Vol. 20, No. 9, 1977, New York J. VAN DIJK et al. "Oxime Ether Derivatives, A New Class of Nonsteroidal Antiinflammatory Compounds" pages 1199 to 1206 * page 1205, method n * *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352832A1 (de) * 1988-07-05 1990-01-31 Akzo N.V. Verbindungen mit bronchodilatatorischer Aktivität
EP0435687A2 (de) * 1989-12-28 1991-07-03 Sumitomo Chemical Company, Limited Verfahren zur Isomerisierung von Oximethern
EP0435687A3 (en) * 1989-12-28 1991-11-21 Sumitomo Chemical Company, Limited Process for isomerization of oxime ethers
US5130486A (en) * 1989-12-28 1992-07-14 Sumitomo Chemical Company Limited Process for isomerization of oxime ethers
WO1993021157A2 (de) * 1992-04-22 1993-10-28 Hoechst Schering Agrevo Gmbh Akarizide, insektizide und nematizide substituierte (hetero)-aryl-alkyl-ketonoxim-o-ether, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
WO1993021157A3 (de) * 1992-04-22 1994-02-03 Hoechst Ag Akarizide, insektizide und nematizide substituierte (hetero)-aryl-alkyl-ketonoxim-o-ether, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
US5728696A (en) * 1992-04-22 1998-03-17 Hoechst Aktiengesellschaft Acaricidal, insecticidal and nematicidal substituted (hetero)arylalkyl ketone oxime O-ethers, processes for their preparation, agents containing them, and their use as pesticides
US5646147A (en) * 1992-04-22 1997-07-08 Hoechst Aktiengesellschaft Acaricidal, insecticidal and nematicidal substituted (hetero)arylalkyl ketone oxime O-ethers, processes for their preparation, agents containing them, and their use as pesticides
US5442063A (en) * 1992-11-02 1995-08-15 Shionogi & Co., Ltd. Process for producing (E)-alkoxyimino or hydroxyimino-acetamide compounds and intermediates therefor
US5627284A (en) * 1992-11-02 1997-05-06 Shionogi & Co., Ltd. Process for producing (E)-alkoxyimino or hydroxyiminoacetamide compounds and intermediates therefor
EP0596692A3 (de) * 1992-11-02 1995-03-08 Shionogi & Co Verfahren zur Herstellung von (E)-Alkoximino- oder Hydroxyiminoacetamidverbindungen und Zwischenprodukte.
EP0596692A2 (de) * 1992-11-02 1994-05-11 Shionogi Seiyaku Kabushiki Kaisha Verfahren zur Herstellung von (E)-Alkoximino- oder Hydroxyiminoacetamidverbindungen und Zwischenprodukte
US6670382B2 (en) 2000-06-15 2003-12-30 Taisho Pharmaceutical Co., Ltd. Hydroxyformamidine derivatives and medicines containing the same
CN103497129A (zh) * 2013-09-05 2014-01-08 湖南海利化工股份有限公司 一种反式硫氟肟醚的制备方法
CN109996793A (zh) * 2017-02-08 2019-07-09 日产化学株式会社 肟基化合物的几何异构体的制造方法
CN109996793B (zh) * 2017-02-08 2022-02-25 日产化学株式会社 肟基化合物的几何异构体的制造方法
US11629124B2 (en) 2017-03-09 2023-04-18 Novartis Ag Solid forms comprising an oxime ether compound, compositions and methods of use thereof

Also Published As

Publication number Publication date
JPS5551049A (en) 1980-04-14
US4158015A (en) 1979-06-12
IL57990A0 (en) 1979-12-30
DD146592A5 (de) 1981-02-18
DK341779A (da) 1980-02-17
ZA794299B (en) 1981-03-25

Similar Documents

Publication Publication Date Title
US4158015A (en) Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
Meyers et al. An asymmetric synthesis of acyclic and macrocyclic. alpha.-alkyl ketones. The role of (e)-and (z)-lithioenamines
EP0158159B1 (de) Verfahren zur Herstellung von O-substituierten Oximverbindungen und deren Umwandlung in die entsprechenden O-substituierten Hydroxylaminverbindungen
EP0113107B1 (de) Verfahren zur Herstellung von Alkoholen
US3998856A (en) Preparation of epoxides
SU957760A3 (ru) Способ получени 5-фтор-2-метилинданон-3-уксусной кислоты
EP0359305B1 (de) Cyclopentanderivate
Saddler et al. Enantioconvergent syntheses of two classes of chiral cyclopentenyl sulfone synthons
Miyamoto et al. Solvent-Free Addition of Ethynylbenzene to Ketones.
US3943157A (en) Synthesis of codling moth attractant
US4596879A (en) Process for producing intermediate furanones from diol derivative and thionyl chloride
EP0435687B1 (de) Verfahren zur Isomerisierung von Oximethern
UA127895C2 (uk) Удосконалений спосіб одержання проміжних сполук
US4681952A (en) Intermediates in the preparation of 2,2-dimethyl-3-aryl-cyclopropanecarboxylic acids and esters
EP0037588B1 (de) Verfahren zur Herstellung von Furfurylalkoholen
EP1516879A1 (de) Verfahren zur Herstellung von Pyran
EP0006254A1 (de) Benzoinoxime-Derivate, Verfahren zu ihrer Herstellung, Zusammensetzungen die solche Derivate enthalten und ihre Verwendung als Fungizide
EP0872473A2 (de) Verfahren zur Herstellung von Chlorketoaminen aus Carbamaten
KR0145712B1 (ko) 살균제 조성물
US4171371A (en) Diketones
AU595040B2 (en) Cyclohexane-1, 3-dione herbicides
Zhang et al. Synthesis of sulfones from arenesulfonyl chlorides and alkyl halides using the Sm/HgCl2 bimetallic system
GB2141427A (en) Herbicidal cyclohexane-1,3-dione derivatives
IL43480A (en) Pyrocatechol mono-ethers and their production
HU191831B (en) Process for producing 2-thiopfencacetic acid derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT NL

17P Request for examination filed
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: RHONE-POULENC INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19830527

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PAUL, JILL HELAINE